| scholarly article | Q13442814 |
| P50 | author | Nora Mattion | Q57314858 |
| P2093 | author name string | Claudia Perez Beascoechea | |
| Cristina Seki | |||
| Eduardo Maradei | |||
| Sabrina Galdo Novo | |||
| Viviana Malirat | |||
| Andrea Pedemonte | |||
| Ricardo D'Aloia | |||
| Ingrid E Bergmann | |||
| Cristina I Balette | |||
| Elizabeth Oviedo Benitez | |||
| Jorge Rodríguez Toledo | |||
| José L La Torre | |||
| P2860 | cites work | MEGA5: Molecular Evolutionary Genetics Analysis Using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods | Q27860929 |
| The suitability of the 'emergency' foot-and-mouth disease antigens held by the International Vaccine Bank within a global context | Q33444445 | ||
| Vital elements for the successful control of foot-and-mouth disease by vaccination | Q33589229 | ||
| The economic impact of foot and mouth disease and its control in South-East Asia: a preliminary assessment with special reference to Thailand. | Q33726098 | ||
| Binary ethylenimine as an inactivant for foot-and-mouth disease virus and its application for vaccine production | Q34537049 | ||
| Review of the status of foot and mouth disease in countries of South America and approaches to control and eradication | Q35043494 | ||
| Evolving perception on the benefits of vaccination as a foot and mouth disease control policy: contributions of South America | Q36350592 | ||
| Serological and biochemical analysis of some recent type A foot-and-mouth disease virus isolates from the Middle East | Q36473112 | ||
| Confidence in indirect assessment of foot-and-mouth disease vaccine potency and vaccine matching carried out by liquid phase ELISA and virus neutralization tests | Q39678471 | ||
| Systematic replacement of amino acid residues within an Arg-Gly-Asp-containing loop of foot-and-mouth disease virus and effect on cell recognition | Q41197317 | ||
| Foot-and-mouth disease virus typing by complement fixation and enzyme-linked immunosorbent assay using monovalent and polyvalent antisera | Q41617413 | ||
| A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C. | Q41743263 | ||
| Characterization of foot-and-mouth disease virus from outbreaks in Ecuador during 2009-2010 and cross-protection studies with the vaccine strain in use in the region. | Q45225160 | ||
| Molecular epidemiology of foot-and-mouth disease virus type A in South America | Q45359130 | ||
| Phylogenetic analysis of Foot-and-Mouth Disease Virus type O circulating in the Andean region of South America during 2002-2008. | Q45366309 | ||
| Updating of the correlation between lpELISA titers and protection from virus challenge for the assessment of the potency of polyvalent aphtovirus vaccines in Argentina. | Q45390397 | ||
| Rapid methodology for antigenic profiling of FMDV field strains and for the control of identity, purity and viral integrity in commercial virus vaccines using monoclonal antibodies | Q45391283 | ||
| Molecular epidemiology of foot-and-mouth disease virus types A and O isolated in Argentina during the 2000-2002 epizootic | Q45404470 | ||
| Phylogenetic analysis of foot-and-mouth disease virus type O re-emerging in free areas of South America | Q45410843 | ||
| Portraits of Viruses: Foot-and-Mouth Disease Virus | Q45799749 | ||
| Generation of a subtype-specific neutralization epitope in foot-and-mouth disease virus of a different subtype | Q45873870 | ||
| Some guidelines for determining foot-and-mouth disease vaccine strain matching by serology | Q57649269 | ||
| Foot-and-mouth disease vaccine potency testing in cattle using homologous and heterologous challenge strains: Precision of the “Protection against Podal Generalisation” test | Q57649276 | ||
| Reintroduction of foot-and-mouth disease in Argentina: characterisation of the isolates and development of tools for the control and eradication of the disease | Q57649292 | ||
| P433 | issue | 2-4 | |
| P921 | main subject | foot-and-mouth disease virus | Q1911079 |
| foot-and-mouth disease | Q152401 | ||
| P1104 | number of pages | 12 | |
| P304 | page(s) | 479-490 | |
| P577 | publication date | 2012-11-07 | |
| P1433 | published in | Veterinary Microbiology | Q15761011 |
| P1476 | title | Characterization of a type O foot-and-mouth disease virus re-emerging in the year 2011 in free areas of the Southern Cone of South America and cross-protection studies with the vaccine strain in use in the region | |
| P478 | volume | 162 |
| Q54219031 | Alternate vaccine strain selection in the wake of emerging foot-and-mouth disease virus serotype A antigenic variants in India. |
| Q40273215 | Antigenic and immunogenic spectrum of foot-and-mouth disease vaccine strain O1 Campos against representative viruses of topotypes that circulated in Asia over the past decade |
| Q51785051 | Efficacy of a high quality O1/Campos foot-and-mouth disease vaccine upon challenge with a heterologous Korean O Mya98 lineage virus in pigs. |
| Q39213600 | Emergence of antigenic variants of Foot-and-Mouth Disease Virus serotype O in Ecuador and preliminary evaluation of a field strain as a vaccine candidate. |
| Q38851217 | Global Foot-and-Mouth Disease Research Update and Gap Analysis: 3 - Vaccines |
| Q42201846 | No significant differences in the breadth of the foot-and-mouth disease serotype A vaccine induced antibody responses in cattle, using different adjuvants, mixed antigens and different routes of administration |
| Q30252156 | Review of the Global Distribution of Foot-and-Mouth Disease Virus from 2007 to 2014. |
| Q47160644 | Selection of vaccine strains for serotype O foot-and-mouth disease viruses (2007-2012) circulating in Southeast Asia, East Asia and Far East |
Search more.